A model for medication safety event detection
- PMID: 20348558
- PMCID: PMC2912034
- DOI: 10.1093/intqhc/mzq014
A model for medication safety event detection
Abstract
Background: Hospital medication safety event detection predominantly emphasizes the identification of preventable adverse drug events (ADEs) through self-reports. These relatively rare events only provide insight into patient harm and self-reports identify only a small portion of ADEs. A broader system-focused approach to medication safety event detection that uses an array of event detection methods is recommended. This approach illuminates medication system deficits and supports improvement strategies that can prevent future patient risk.
Objective: To: (i) describe a system-focused approach to hospital medication safety event detection, and (ii) present a case illustration of approach application. SYSTEM-FOCUSED MODEL AND METHODOLOGY: A three-level medication safety event detection model that ranges from a narrow harm-focused to broader system-focused approach is described. A standardized cross-level methodology to detect medication safety events is presented.
Case illustration: A Level 3 system-focused methodology that incorporated both voluntary and non-voluntary event detection strategies was used in 17 critical care (n = 4), intermediate care (n = 7) and medical-surgical units (n = 6) across two hospitals. A total of 431 events were detected: 78 (18.1%) ADEs and 353 (81.9%) potential ADEs. Of the 353 PADEs, 302 (70.0%) were non-intercepted events. Non-voluntary detection methods yielded the majority of events (367, 85.1%).
Conclusions: The incidence of ADEs was low when compared with non-intercepted PADEs. This was indicative of medication safety system failures that placed patients at risk for potential harm. Non-voluntary detection methods were much more effective at detecting events than traditional self-report methods.
Figures
Similar articles
-
Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.Pediatrics. 2008 Apr;121(4):e927-35. doi: 10.1542/peds.2007-1779. Pediatrics. 2008. PMID: 18381521
-
Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.Paediatr Drugs. 2009;11(2):153-60. doi: 10.2165/00148581-200911020-00005. Paediatr Drugs. 2009. PMID: 19301935
-
Identifying drug safety issues: from research to practice.Int J Qual Health Care. 2000 Feb;12(1):69-76. doi: 10.1093/intqhc/12.1.69. Int J Qual Health Care. 2000. PMID: 10733086 Review.
-
Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.Pediatrics. 2008 May;121(5):e1201-7. doi: 10.1542/peds.2007-2609. Pediatrics. 2008. PMID: 18450863
-
The epidemiology of preventable adverse drug events: a review of the literature.Wien Klin Wochenschr. 2003 Jul 15;115(12):407-15. doi: 10.1007/BF03040432. Wien Klin Wochenschr. 2003. PMID: 12918183 Review.
Cited by
-
Validation of an assessment, medical problem-oriented plan, and care plan tools for demonstrating the clinical pharmacist's activities.Saudi Pharm J. 2022 Oct;30(10):1464-1472. doi: 10.1016/j.jsps.2022.07.007. Epub 2022 Jul 25. Saudi Pharm J. 2022. PMID: 36387343 Free PMC article.
-
Potential adverse drug events and its predictors among hospitalized patients at medical center in Ethiopia: a prospective observational study.Sci Rep. 2021 Jun 3;11(1):11784. doi: 10.1038/s41598-021-91281-5. Sci Rep. 2021. PMID: 34083718 Free PMC article.
-
Adverse Drug Events and Contributing Factors Among Hospitalized Adult Patients at Jimma Medical Center, Southwest Ethiopia: A Prospective Observational Study.Curr Ther Res Clin Exp. 2020 Oct 29;93:100611. doi: 10.1016/j.curtheres.2020.100611. eCollection 2020. Curr Ther Res Clin Exp. 2020. PMID: 33296443 Free PMC article.
-
Medication errors in pediatric inpatients: a study based on a national mandatory reporting system.Eur J Pediatr. 2017 Dec;176(12):1697-1705. doi: 10.1007/s00431-017-3023-8. Epub 2017 Oct 1. Eur J Pediatr. 2017. PMID: 28965285
References
-
- Institute of Medicine. To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press; 1999.
-
- Stelfox HT, Palmisani S, Scurlock C, et al. The ‘To Err is Human’ report and the patient safety. Qual Saf Health Care. 2006;15:174–8. doi:10.1136/qshc.2006.017947. - DOI - PMC - PubMed
-
- Classen DC, Metzger J. Improving medication safety: the measurement conundrum and where to start. Int J Qual Health Care. 2003;15:i41–i47. doi:10.1093/intqhc/mzg083. - DOI - PubMed
-
- Bates DW, Cullen D, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274:29–34. doi:10.1001/jama.274.1.29. - DOI - PubMed
-
- Brennan TA, Leape LL, Laird N, et al. Incidence of adverse drug events and negligence in hospitalized patients: results from the Harvard Medical Practice Study I. N Engl J Med. 1991;324:370–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
